News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show.
ASCO 2019: New blood test predicts breast cancer’s return at start of treatment
A new blood test for women with breast cancer can predict how well patients will respond to a new drug right at the start of treatment.
ASCO 2019: ICR-discovered drug shows promise in phase I clinical trial
A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage has shown promising results in two clinical trials.
Scientists discover ‘switch’ that helps breast cancer spread around the body
Researchers have identified a genetic ‘switch’ in breast cancer cells that helps them spread around the body.
Night shifts do not increase breast cancer risk, major UK analysis suggests
Working night shifts is not linked to an increased risk of breast cancer, a major prospective UK analysis has found.
When it comes to cancer, how can DNA become its own enemy?
Dr Gideon Coster is one of the newest Team Leaders at the ICR. Here we take a look at his research, aiming to understand how DNA can become its own enemy.
Opera stars’ encore funds life-saving cancer research
Four of the UK’s leading opera singers have performed an exclusive recital in support of the ICR.
New ‘barcode’ test divides bowel cancer into five diseases
A new test can genetically ‘barcode’ bowel cancer and separate it into five different diseases that could each receive tailored treatment, a new study reports.
How the ICR’s pioneering drug research is changing lives
The ICR has discovered more new cancer drugs than any other academic institution globally, and led the underpinning science for many more cancer treatments. We have helped lead clinical trials of these drugs and many others – taking them to cancer patients as quickly as possible.
Revolutionary new Centre for Cancer Drug Discovery aims to deliver step change in cancer treatment
The world’s first ‘Darwinian’ drug discovery programme specially designed to tackle cancer’s lethal ability to evolve resistance to treatment is to be launched in a state-of-the-art new building in London.
New radiotherapy system that moves patients in sync with x-ray beam can deliver accurate treatment for brain cancer
A new way to deliver radiotherapy that rotates patients in sync with the treatment beam could treat patients with brain cancer as accurately and quickly as the most advanced radiotherapy available, scientists at the ICR show.
New treatment could become first ever targeted therapy designed for ‘untreatable’ childhood brain cancer
A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease. The prototype treatment could also offer hope for patients with the rare and devastating ‘stone man syndrome’ – in which muscles and ligaments turn to bone.
